SITC Resource Library

The Society for Immunotherapy of Cancer (SITC) hosted the Immune Engineering Workshop: Building Bridges Between All Aspects of Engineering and Immuno-oncology during the 39^th Annual Meeting & Pre-Conference Programs on November 7, 2024. Available here are the presentation slides and video from Session II: Successful Interdisciplinary Collaborations” as permitted by presenters.

Program Organizers

• Daniel S. Chen, MD, PhD – Synthetic Design Lab, Inc.
• Elana J. Fertig, PhD, FAIMBE – Johns Hopkins University
• Kole T. Roybal, PhD – University of California, San Francisco
• Stefani Spranger, PhD – Koch Institute for Integrative Cancer Research at MIT

Target Audience

The target audience for this workshop includes engineers, chemists, material scientists, and AI computer scientists as well as basic, translational, and clinical researchers from all work settings with an interest in advances in engineering and immuno-oncology.  

Program Description

The SITC Immune Engineering Workshop helps SITC advance the science and application of engineering and cancer immunotherapy by providing relevant and engaging content to basic, translational, and clinical researchers. This Workshop will explore the recent advances in engineering, artificial intelligence, and cancer immunology and how these fields can converge to effectively address current hurdles in immuno-oncology. The Workshop will explore practical solutions to clinical problems via interdisciplinary collaboration between engineers, clinicians, and scientists. Armed with a deeper understanding of engineering and artificial intelligence in the context of immuno-oncology, attendees will be equipped to effectively collaborate and develop more effective tools and treatments in immuno-oncology, potentially impacting clinical care and leading to better patient outcomes. 

Learning Objectives

At the conclusion of this activity, participants should be able to:

• Describe key or critical issues in engineering that can be addressed by collaborative approaches between engineers and immuno-oncologists 
• Detail engineering-based approaches to modulate the immune response and promote anti-cancer immunity 
• Analyze cutting-edge basic, translational, and clinical studies of engineering to incorporate new research and techniques into clinical applications for cancer immunotherapy

To view the entire program schedule (including presenter permission to post) please click here.